Analysts Lift Targets as Shorts Retreat Before ARWR Print
Arrowhead Pharmaceuticals heads into its August 7 earnings report with the most bullish analyst consensus momentum it has seen in months, even as short sellers quietly pare back positions. The analyst signal is the…
